Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine

被引:47
作者
Shimizu-Tokiwa, A
Kobata, M
Io, H
Kobayashi, N
Shou, I
Funabiki, K
Fukui, M
Horikoshi, S
Shirato, I
Saito, K
Tomino, Y
机构
[1] Juntendo Univ, Sch Med, Div Nephrol, Dept Internal Med,Bunkyo Ku, Tokyo 1138421, Japan
[2] Dade Behring Ltd, Mkt Div, Tokyo, Japan
来源
NEPHRON | 2002年 / 92卷 / 01期
关键词
serum cystatin C; serum creatinine; creatinine clearance; chronic renal failure;
D O I
10.1159/000064453
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We determined the relationship between the levels of serum cystatin C or creatinine (s-Cr) and the grade of creatinine clearance (CCr) in patients with various glomerular diseases. Serum samples from 96 patients with glomerular diseases were obtained from our hospital. The levels of serum cystatin C were measured using the Dade Behring Cystatin C assay with the automated Dade Behring Nephelometer II (BNII). CCr levels were classified into six groups according to the Guidelines of the Japanese Society of Nephrology as follows: grade 1 (normal renal function); grade 2 (slight decrease of renal function); grade 3 (moderate decrease of renal function); grade 4 (severe decrease of renal function); grade 5 (renal failure), and grade 6 (uremia). The mean levels of serum cystatin C in grade 3 patients were significantly higher than those in grade 1. The mean levels of serum cystatin C in grades 4, 5 and 6 patients were also significantly higher than those in grade 1. However, the mean levels of serum Cr in grade 3 patients were not significantly higher than those in grade 1. The levels of s-Cr in grades 4, 5 or 6 patients were significantly higher than those in grade 1. In this study, an increase of serum cystatin C levels occurred earlier than that of s-Cr in various glomerular diseases. It appears that the levels of serum cystatin C may provide early prognostic marker of patients with various glomerular diseases rather than the levels of s-Cr. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:224 / 226
页数:3
相关论文
共 8 条
[1]   THE PLACE OF HUMAN GAMMA-TRACE (CYSTATIN-C) AMONGST THE CYSTEINE PROTEINASE-INHIBITORS [J].
BARRETT, AJ ;
DAVIES, ME ;
GRUBB, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :631-636
[2]   Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II system [J].
Erlandsen, EJ ;
Randers, E ;
Kristensen, JH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1999, 59 (01) :1-8
[3]  
KUROKAWA K, 1998, GUIDELINES DAILY LIV, P44
[4]   SERUM CYSTATIN-C MEASURED BY AUTOMATED IMMUNOASSAY - A MORE SENSITIVE MARKER OF CHANGES IN GFR THAN SERUM CREATININE [J].
NEWMAN, DJ ;
THAKKAR, H ;
EDWARDS, RG ;
WILKIE, M ;
WHITE, T ;
GRUBB, AO ;
PRICE, CP .
KIDNEY INTERNATIONAL, 1995, 47 (01) :312-318
[5]  
OHARA T, 2000, MED PHARM, V43, P835
[6]   THE BLOOD-SERUM CONCENTRATION OF CYSTATIN-C (GAMMA-TRACE) AS A MEASURE OF THE GLOMERULAR-FILTRATION RATE [J].
SIMONSEN, O ;
GRUBB, A ;
THYSELL, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (02) :97-101
[7]  
Tomino Y, 2001, J CLIN LAB ANAL, V15, P25, DOI 10.1002/1098-2825(2001)15:1<25::AID-JCLA5>3.0.CO
[8]  
2-Y